Team
Yuki Ishimoto Yuki Ishimoto
Venture
After graduating from the Department of Veterinary Medicine, School of Veterinary Medicine, Azabu University, Yuki Ishimoto worked at Ono Pharmaceutical, later joining JAFCO in September 2023. In the Industry-Academia Life Science Investment Group of the Investment Division, he is in charge of sourcing portfolio companies, executing investments, and providing post-investment support services mainly for startups in the life science field. He is an MBA.
Before joining JAFCO, I was engaged in the search for in-licensing candidate compounds, scientific and business feasibility evaluations, and out-licensing activities at the business development division and the US branch office of Ono Pharmaceutical. In addition, I was engaged in the consideration of expansion in Asia and business support for local subsidiaries in the overseas business division. I aim to contribute to people's happiness and health by acting as a bridge between technology, business, and finance, utilizing the knowledge I have accumulated in the life sciences field and my experience in business development.
Portfolio
株式会社アークメディスン
Alchemedicine
Category
Healthcare / Biotech
Initial Investment
2021
アリヴェクシス株式会社
Alivexis, Inc.
Category
Healthcare / Biotech
Initial Investment
2020
Magenta Medical Ltd.
Magenta Medical Ltd.
Category
Healthcare / Biotech
Initial Investment
2017
PRD Therapeutics株式会社
PRD Therapeutics,Inc.
Category
Healthcare / Biotech
Initial Investment
2023
リジェネフロ株式会社
Rege Nephro Co.,Ltd.
Category
Healthcare / Biotech
Initial Investment
2020
株式会社Arrowsmith
Arrowsmith, inc.
Category
Healthcare / Biotech
Science and Engineering
Sustainablility
Initial Investment
2025